2m 2m 2m 2m 2m 2m 2m
Syndax Pharmaceu (SNDX)
NASDAQ
$23.12+$0.22 (+0.98%)
Price as of Jul 13, 2026 6:18 PM EDT- $2.1BMarket Cap
- 132.39%1-Year Change
- BiotechnologyIndustry
Syndax Pharmaceu (SNDX)
$23.12+$0.22 (+0.98%)
SNDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $22.89 | ||
Change | -$0.72 (-3.05%) | ||
Open | $23.21 | ||
High | $23.32 | ||
Low | $22.26 | ||
Previous Close | $23.61 | ||
Volume | 1,422,954 | ||
30-Day Average Volume | 2,398,107 | ||
1-Week Change | 3.67% | ||
1-Month Change | 25.42% | ||
1-Year Change | 132.39% | ||
3-Year Change | 11.88% | ||
5-Year Change | 41.21% | ||
Fundamentals | |||
Shares Outstanding | 88.6M | ||
Total Assets | $472.7M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.7B | ||
Period: QTR TTM FY | |||
Revenue | $48.9M | ||
Net Income | -$42.7M | ||
Free Cash Flow | -$50.3M | ||
EBIT | -$30.9M | ||
EBITDA | -$26.9M | ||
Net Working Capital | $385.0M | ||
EPS | -$0.48 | ||
Enterprise Value/EBITDA | -99 | ||
Enterprise Value/Revenue | 54 | ||
P/B | 50 | ||
P/E | -49 | ||
PEG | -1 | ||
Price/Free Cash Flow | -42 | ||
Price/Operating Cash Flow | -42 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue